Clinical Development Support
CEBIS supports pharmaceutical, biotechnology, biosimilar, medical device, generic drug and nutraceutical development with integrated clinical, regulatory, data, statistical, safety, quality and bioanalytical support.
Experience Across a Range of
Development Programs
Different sponsors face different clinical, regulatory and operational challenges. CEBIS supports programs with flexible services that can be delivered individually or as part of a coordinated development approach.
This approach allows sponsors to access the specific expertise they need while keeping clinical, operational, data, regulatory, safety and quality activities aligned across the program.
Pharmaceutical Companies
CEBIS supports pharmaceutical companies across the clinical development lifecycle, from early-stage planning and Phase I studies through Phase II–III trials, late-phase research and post-marketing programs.
Clinical operations, regulatory affairs, data management, biostatistics, medical writing, safety, quality and supporting services can be provided individually or coordinated around the broader development program.
Biotechnology Companies
CEBIS provides flexible clinical-development support for biotechnology companies that may require specialized expertise while internal teams remain focused or continue to evolve.
Clinical, regulatory, data, statistical, safety, medical-writing, quality and operational services can be scaled around the product, development stage and structure of the sponsor team.
Large Molecule & Biosimilar Developers
Large-molecule, biologic and biosimilar programs can require close coordination across clinical execution, pharmacokinetic or bioanalytical activities, data review, safety oversight and regulatory planning.
CEBIS can provide focused services or coordinate multiple functions around the study and development objectives.
Medical Device Companies
CEBIS supports medical-device development across clinical and regulatory activities, including clinical evidence generation, clinical evaluation, technical documentation and post-market clinical follow-up.
Support can be adapted to the device, development stage, intended market and evidence requirements of the program.
Generic Drug Developers
CEBIS supports generic-drug development through coordinated bioavailability and bioequivalence studies, pharmacokinetic evaluation, bioanalysis, data management, biostatistics, reporting and regulatory support.
Clinical and analytical activities can be aligned around the formulation, study design and regulatory objectives of the program.
Nutraceutical Organizations
CEBIS supports nutraceutical and related product-development programs requiring clinical evidence, safety and efficacy assessment, regulatory support and study execution.
Services can be coordinated around the product, target claims, evidence requirements and development objectives.
Flexible Support Built Around the Program
Looking for Support for Your Development Program?
Tell us about your organization, development stage and study requirements. A member of the CEBIS team will contact you to discuss the appropriate next steps.